Nottingham Advisors, Inc. Bristol Myers Squibb CO Transaction History

Nottingham Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $159,476 - $231,756	-3,437 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $169,134 - $220,621	3,437 New	3,437 $221,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $175,228 - $197,643	-3,175 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $27,263 - $31,385	-455 Reduced 12.53%	3,175 $201,000
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $3,296 - $3,594	55 Added 1.54%	3,630 $222,000
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $197,447 - $227,870	3,575	3,575 $228,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nottingham Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Nottingham Advisors, Inc. with notifications on news.